Home › Funds › Frazier Life Sciences Management, L.P. › MNKD

Frazier Life Sciences Management, L.P. position in MNKD

MANNKIND CORP · Health Care

Frazier Life Sciences Management, L.P. reported holding 6,600,000 shares of MNKD (MANNKIND CORP) in its Q2 2026 13F filing — a position valued at US$28.1M, representing 0.61% of its reported portfolio and ranking #27 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed MNKD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)6.60M sh
Reported value held$28.12M
Portfolio Weight0.61%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s MNKD position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in MNKD in Q4 2025 at 4,225,000 shares (US$24.0M). The position peaked in Q2 2026 at 6,600,000 shares, worth US$28.1M. Across 3 filings, Frazier Life Sciences Management, L.P. increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,600,000 shares valued at US$28.1M — an increase of 700,000 shares quarter over quarter.. Notable position changes include a 40% increase in Q1 2026 (shares rose 74% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.22M $23.96M New
Q1 2026 5.90M $14.46M Add
Q2 2026 6.60M $28.12M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MNKD and 13F data

MNKD (MANNKIND CORP) is a Health Care company. 26 other funds we track also report a position in MNKD — the largest reported positions include Rubric Capital Management LP (US$76.7M), Deep Track Capital, LP (US$25.6M), TSP Capital Management Group, LLC (US$16.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MNKD

All MNKD fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held MNKD?

Frazier Life Sciences Management, L.P. has disclosed MNKD holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Frazier Life Sciences Management, L.P.'s current position in MNKD?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 6.60M shares of MNKD (MANNKIND CORP), valued at $28.12M, representing 0.61% of its reported portfolio and ranking #27.

Has Frazier Life Sciences Management, L.P. been buying or selling MNKD?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. increased its position in MNKD. The position peaked in Q2 2026 at 6.60M shares.

Which other funds hold MNKD?

Other major institutional holders of MNKD include Rubric Capital Management LP, Deep Track Capital, LP, TSP Capital Management Group, LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.